As previously observed in sarcoma-injected animals [11], substance P (SP) and isolectin B4 (IB4) immunoreactivities, labeling peptidergic and non-peptidergic small projecting nociceptive fibers, respectively, remained unchanged (data not shown). Here, TAC1 is linked to sarcoma.